drug abuse Solvd Health Gets CE Mark for Opioid Use Disorder Risk Assessment Test The genetic test is currently under review by the US Food and Drug Administration, which granted it a breakthrough device designation in 2018. Prescient Medicine Acquires AutoGenomics Prescient will further the development and commercialization of the Infiniti Neural Response Panel to identify patients who may be at risk for opioid use disorder. Opioid Dependence Linked to Decreased Methylation in Several Genes An epigenome-wide association study in women with opioid dependence led to hypomethylated sites in three genes involved in various cellular processes. Opium Poppy Genome Provides Look at Painkiller Compound Evolution After a series of duplication and rearrangement events, the genes involved in two key pathways producing morphine, codeine, and noscapine have clustered in the genome. U of Michigan Precision Health Effort Looking Beyond Genomics in Researching Opioid Crisis Premium The university is marshaling the expertise across all its schools in studying myriad factors that might contribute to opioid response, addiction, and abuse. Jul 29, 2016 InSource Diagnostics Clinical Trial Explores Pharmacogenetics Premium Mar 30, 2016 GWAS Identifies Loci Linked to Cannabis Dependence Jul 7, 2015 BioRealm SmokeScreen Genotyping Array Looks to Boost Drug Addiction Research Premium Oct 10, 2014 NIDA Awards U of Chicago $12M to Create Center for Genetics-based Drug Abuse Research Aug 30, 2013 NIH to Fund Projects Focused on Genetic, Epigenetic Basis of Drug and Alcohol Co-addiction Aug 29, 2013 NIDA to Fund Genetic, Molecular Studies of Chronic Drug Abuse Jun 11, 2012 NIDA Wants Education Programs to Use Genetic Data in Addiction Research Jul 22, 2011 NIH to Fund Substance Use Gene-Environment Studies Jul 28, 2010 NIDA Seeks Small Businesses with PGx Expertise to Guide Research on Rx Addiction Premium Jan 29, 2010 NIDA Plans $10M for Addiction Genomics Research Jan 7, 2010 Epigenetic Pathway Linked To Cocaine-Related Brain Changes in Mice Dec 30, 2009 Genetic Studies Offer Clues about Addiction Risks, Treatments Sep 2, 2009 Catalyst Pharma Partners Licenses GABA Aminotransferase Inhibitors from Northwestern U Premium Mar 25, 2009 Genetically Stratifying Smoking-Cessation Trials Could Save Up to $15M, Researchers Find Premium Feb 4, 2009 Snippets: Feb 4, 2009 Premium Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.